Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Kv1.3 potassium voltage-gated channel subfamily A member 3 is a tetrameric ion channel found primarily on immune cells, such as T lymphocytes and microglia. Structurally, each subunit contains six transmembrane segments with distinct voltage-sensing and ion-conducting domains, featuring a highly conserved selectivity filter that discriminates potassium from sodium ions. Kv1.3 channels regulate the membrane potential and calcium-dependent signaling pathways crucial for immune cell activation and proliferation. Functionally, they are integral to immune responses, and their upregulation is notable in several autoimmune and neuroinflammatory conditions. Kv1.3 blockade is being explored as an immunosuppressive therapeutic strategy in the treatment of these diseases. Despite promise, systemic inhibition may pose immunosuppressive risks and off-target effects due to the channel's broader expression profile. The molecular characterization and strong evidence linking Kv1.3 to disease pathology establish it as a significant drug target.
Channel blockade (inhibition of potassium efflux, leading to altered membrane potential and suppressed T cell activation); Stabilization of channel selectivity filter (peptides/nanobodies can lock the channel in a non-conducting or open state); Immunosuppression by impairing calcium signaling in effector T cells
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Kv1.3 potassium voltage-gated channel subfamily A member 3 (Kv1.3).